[Septic arthritis as an initial manifestation of a bacterial endocarditis].
Septic arthritis due to endocarditis is a rare and life-threatening disease. Endocarditis occurs with an incidence of 30 patients per 1 million citizens/year. Staphylococcus aureus is one of the most common causative pathogens. Methicillin-resistant Staphylococcus aureus (MRSA) can lead to a severe outcome with a high mortality rate, and embolic complications of the kidney, brain, and spleen are seen in one third of all cases. The diagnosis and treatment of endocarditis is a challenge for all health care providers. We report about a patient who was admitted to our hospital with generalized sepsis of unknown origin.
Chirurgische Klinik und Poliklinik, Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil, Ruhr-Universität Bochum, Bürkle-de-la-Camp Platz 1, 44789, Bochum, Deutschland. mgothner@gmx.de
M
M
Gothner
T
T
Ramczykowski
A
A
Ewers
T
T
Kälicke
S
S
Shah
T A
TA
Schildhauer
J
J
Swol
D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001170:Arthritis, Infectious / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy*; D001182:Arthroscopy / Q000379:methods; D003131:Combined Modality Therapy; D003937:Diagnosis, Differential; D004697:Endocarditis, Bacterial / Q000150:complications / Q000175:diagnosis* / Q000628:therapy*; D017809:Fatal Outcome; D006801:Humans; D008297:Male; D055624:Methicillin-Resistant Staphylococcus aureus; D013203:Staphylococcal Infections / Q000150:complications / Q000175:diagnosis* / Q000628:therapy*; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents